Acadian Asset Management LLC Actinium Pharmaceuticals, Inc. Transaction History
Acadian Asset Management LLC
- $34.5 Billion
- Q4 2024
A detailed history of Acadian Asset Management LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 499,260 shares of ATNM stock, worth $574,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
499,260
Previous 453,694
10.04%
Holding current value
$574,149
Previous $851,000
26.2%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$791,0300.0% of portfolio
-
State Street Corp Boston, MA621KShares$714,2360.0% of portfolio
-
Northern Trust Corp Chicago, IL252KShares$289,7190.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $29M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...